Article
A novel parC mutation potentiating fluoroquinolone resistance in Klebsiella pneumoniae and Escherichia coli clinical isolates.
Journal of infection in developing countries - 28 Feb 2022
Yakout Marwa Atef, Ali Ghada Hani
Abstract excerpt
INTRODUCTION: Resistance to fluoroquinolones is mainly due to point mutations that gave rise to amino acid substitutions in the quinolone resistance-determining regions of either gyrA or parC genes, which may be augmented by plasmid mediated resistance. Accordingly, the main aim of the study was to investigate the mutations in gyrA and parC genes as well as the qnrA and qnrB genes acquisition. METHODOLOGY: 193...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
